Sera Prognostics, Inc.
SERA Nasdaq
SEC CIK 1534969
Follow Sera Prognostics
Weekly email: filings, results
Revenue, last quarter
$42K
+162.5% vs same quarter last year
Net income
−$8.1M
−3.1% vs same quarter last year
EPS, diluted
−$0.16
+0% vs same quarter last year
Operating cash flow
−$7.3M
−12.7% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $81K | −$31.9M |
| FY24 | $77K | −$32.9M |
| FY23 | $306K | −$36.2M |
| FY22 | $268K | −$44.2M |
| FY21 | $82K | −$35M |
| FY20 | $25K | −$19.8M |
| FY19 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | −102.5% | −45066.7% | −39417.3% |
| FY24 | −6.5% | −47577.9% | −42724.7% |
| FY23 | 31.4% | −13013.4% | −11843.8% |
| FY22 | - | −17034.3% | −16487.3% |
| FY21 | - | −43164.6% | −42693.9% |
| FY20 | - | −71884% | −79392% |
| FY19 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$26.3M |
| FY24 | −$14.2M |
| FY23 | −$27.3M |
| FY22 | −$35.4M |
| FY21 | −$32.9M |
| FY20 | −$17M |
| FY19 | - |
- Sera Prognostics
- Healthcare median
Show the numbers
| Year | Sera Prognostics | Healthcare median |
|---|---|---|
| FY25 | −39417.3% | −30.6% |
| FY24 | −42724.7% | −47% |
| FY23 | −11843.8% | −58% |
| FY22 | −16487.3% | −80.4% |
| FY21 | −42693.9% | −71.8% |
| FY20 | −79392% | −62.2% |
| FY19 | - | −46.2% |